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How to escape from a macrophage
L
ike a well-trained police dog, a macro-
phage responds to a signal that means 
“let go.” Tsai and Discher reveal that the 
signal works by blocking a molecular motor that 
helps drag bacteria and other potential enemies 
into the macrophage.
Macrophages sweep up pathogens while 
leaving our own cells alone. A two-step procedure 
for recognizing intruders helps avoid misdirect-
ed attacks. In the ﬁ  rst step, macrophages snare 
and begin swallowing objects studded with IgG 
antibodies, which usually latch onto interlopers. 
But the antibodies are sloppy, sometimes attach-
ing to the body’s own cells. So before a macro-
phage engulfs its target, it also checks for a 
second form of identiﬁ  cation, the protein CD47. 
If a “self” version of CD47 is present, it induces 
the macrophage to disengage. How CD47 
spurs a macrophage to stop mid-swallow was 
uncertain.
To ﬁ nd out, Tsai and Discher followed human 
macrophages as they tangled with human and 
sheep red blood cells. When a macrophage 
meets its quarry, actin molecules ﬂ  ock to the 
contact site and polymerize, extending the cell’s 
membrane around the target. Another protein 
called nonmuscle myosin also moves in. It con-
tracts to help reel in the partly engulfed object. 
The researchers found that actin and nonmuscle 
myosin relocated normally when the macro-
phages encountered sheep red blood cells, which 
sport a “foreign” version of CD47. But when the 
targets were human red blood cells—which carry 
self CD47—only actin is mobilized.
Further experiments indicated that CD47 
exerts its effects through its receptor on macro-
phages, SIRPα, which in turn indirectly inacti-
vates the myosin by preventing the addition of a 
phosphate group to the brawny molecule. By 
shutting down a pulling protein needed to com-
plete phagocytosis, the researchers conclude, 
self CD47 prevents cells that carry it from being 
eaten. The team speculates that macrophages 
beneﬁ   t from the two-step recognition process 
because it allows them to restrain a potential 
troublemaker while checking its credentials. As 
a result, they are poised to gobble the target if 
it turns out to be a threat. 
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Making the wrong connections in epilepsy
A 
matrix enzyme that helps us learn 
and remember might also promote 
epilepsy, as Wilczynski et al. 
report. The enzyme might clear the way 
for abnormal links between brain cells.
Researchers think that epileptic seizures 
are the result of aberrant synapses between 
neurons that create stimulatory circuits. 
However, the rearrangement of neural 
circuits, known as synaptic plasticity, also 
allows learning and memory. Recent 
studies have shown that the enzyme matrix 
metalloproteinase 9 (MMP-9), which dis-
solves the extracellular matrix, is essential 
for synaptic plasticity. Wilczynski et al. 
wanted to determine whether MMP-9 also 
helps spur epilepsy.
The researchers gave rodents either of 
two drugs that trigger epilepsy. Mice lack-
ing MMP-9 were less likely to start having 
seizures than were control animals, and 
their attacks were less severe. The team 
then tested a line of genetically modifi  ed 
rats they had developed that pump out 
extra amounts of MMP-9. These rodents 
were particularly susceptible to seizures.
Two types of synaptic plasticity oc-
curred in mice that made MMP-9. First, 
the short spines that protrude from den-
drites withered. Their shrinkage might 
open space for new synapses, the re-
searchers speculate. Second, axons sprout-
ed outgrowths called 
mossy fi  bers that link 
up with other cells. 
MMP-9’s absence in-
hibited both types of 
plasticity, the research-
ers found.
The work indicates 
that MMP-9 helps pro-
voke epileptic seizures, 
possibly by rebuilding 
the extracellular matrix 
so that neurons can form new connections. 
MMP-9 is in the right place to perform 
that job, the team found: it accumulates 
at brain synapses. The results raise the 
possibility that drugs to block metallo-
proteinases, which are under develop-
ment as cancer treatments, might also 
work against epilepsy. 
Wilczynski, G.M., et al. 2008. J. Cell Biol. 
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Fewer brain synapses sprout after treatment with an MMP-9 inhibitor 
(left) than in a control (right).
A macrophage grabs but does 
not swallow a human red blood 
cell (arrow) carrying CD47.